This study has been completed. The goal of the Phase I part of this clinical research study is to find the highest tolerable dose of a combination of dasatinib, cetuximab, and FOLFOX (5-fluorouracil [5-FU], leucovorin [LV], and Eloxatin [oxaliplatin]) that can be given to patients with metastatic colorectal cancer. The safety of these drugs in combination will also be studied.
Shingles is a painful, usually blistering skin rash typically found on one side of the body, wrapping around the trunk or waist. But it can appear anywhere from the head, arms, chest, abdomen or buttocks down to the feet.
A case of shingles can last for up to a few weeks or more. The early symptoms include pain, itching, tingling, or a burning sensation at one location on the body, such as one side of the waist or face. A few days after these symptoms begin, the skin on the afflicted body part develops fluid-filled blisters.